A
Anuradha Lala
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 155
Citations - 6472
Anuradha Lala is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 31, co-authored 112 publications receiving 3528 citations. Previous affiliations of Anuradha Lala include Cardiovascular Institute of the South & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Standing the test of time.
Anuradha Lala,Judith S. Hochman +1 more
TL;DR: In 1967, Dr. Thomas Killip and Dr. John Kimball reported their experience with a novel construct called the coronary care unit to cluster and care for patients with suspected acute myocardial infarction, and this work aims to provide a clinical estimate of the severity of my cardiac derangement.
Journal ArticleDOI
Pulmonary Artery Pressure Monitoring during the COVID-19 Pandemic in New York City.
Journal ArticleDOI
Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
Bart S. Ferket,Gorav Ailawadi,Annetine C. Gelijns,Michael A. Acker,Samuel F. Hohmann,Helena L. Chang,Denis Bouchard,David O. Meltzer,Robert E. Michler,Ellen Moquete,Pierre Voisine,John C. Mullen,Anuradha Lala,Michael J. Mack,A. Marc Gillinov,Vinod H. Thourani,Marissa A. Miller,James S. Gammie,Michael K. Parides,Emilia Bagiella,Robert L. Smith,Peter K. Smith,Judy Hung,Lopa Gupta,Eric A. Rose,Patrick T. O'Gara,Alan J. Moskowitz +26 more
TL;DR: The CTSN (Cardiothoracic Surgical Trials Network) recently reported no difference in left ventricular end-systolic volume index or in survival at 2 years between patients with severe is... as discussed by the authors.
Journal ArticleDOI
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failure.
Robert J. Mentz,Haolin Xu,Emily C. O'Brien,Laine Thomas,Tamas Alexy,Bhanu Gupta,Juan Vilaro,Anuradha Lala,Adam D. DeVore,Ravi Dhingra,Alexandros Briasoulis,Marc A. Simon,Josef Stehlik,Jo E. Rodgers,Shannon M. Dunlay,Martha Abshire,Quinn S. Wells,Kurt G. Barringhaus,Peter M. Eckman,Brian D. Lowes,Johana Espinoza,Rosalia Blanco,Xian Shen,Carol I. Duffy,Adrian F. Hernandez +24 more
TL;DR: In this prospective HFrEF study of sacubitril/valsartan initiation compared with recent ACE-I/ARB initiation/dose change, the between-group difference in the primary endpoint, mean Kansas City Cardiomyopathy Questionnaire (KCCQ) change at 12weeks, was not statistically significant following adjustment.
Journal ArticleDOI
Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.
Bart S. Ferket,Vinod H. Thourani,Pierre Voisine,Samuel F. Hohmann,Helena L. Chang,Peter K. Smith,Robert E. Michler,Gorav Ailawadi,Louis P. Perrault,Marissa A. Miller,Karen O'Sullivan,Stephanie Mick,Emilia Bagiella,Michael A. Acker,Ellen Moquete,Judy Hung,Jessica Overbey,Anuradha Lala,Margaret Iraola,James S. Gammie,Annetine C. Gelijns,Patrick T. O'Gara,Alan J. Moskowitz,Wendy C. Taddei-Peters,Dennis Buxton,Ron Caulder,Nancy L. Geller,David Gordon,Neal Jeffries,Albert Lee,Claudia S. Moy,Ilana Kogan Gombos,Jennifer Ralph,Richard D. Weisel,Timothy J. Gardner,Eric A. Rose,Michael K. Parides,Deborah D. Ascheim,Helena Chang,Melissa Chase,Yingchun Chen,Seth Goldfarb,Lopa Gupta,Katherine A. Kirkwood,Edlira Dobrev,Ron Levitan,Jessica Overbey,Milerva Santos,Michael Weglinski,Paula Williams,Carrie Wood,Xia Ye,Sten Lyager Nielsen,Henrik Wiggers,Henning Malgaard,Michael J. Mack,Tracine Adame,Natalie Settele,Jenny Adams,William H. Ryan,Robert L. Smith,Paul A. Grayburn,Frederick Y. Chen,Anju Nohria,Lawrence H. Cohn,Prem Shekar,Sary F. Aranki,Gregory S. Couper,Michael H. Davidson,R. Morton Bolman,Anne Burgess,Debra Conboy,Nicolas Noiseux,Louis M Stevens,Ignacio Prieto,Fadi Basile,Joannie Dionne,Julie Fecteau,Eugene H. Blackstone,A. Marc Gillinov,Pamela Lackner,Leoma Berroteran,Diana Dolney,Suzanne Fleming,Roberta Palumbo,Christine Whitman,Kathy Sankovic,Denise Kosty Sweeney,Gregory Pattakos,Pamela A. Clarke,Michael Argenziano,Mathew R. Williams,Lyn Goldsmith,Craig R. Smith,Yoshifumi Naka,Allan S. Stewart,Allan Schwartz,Daniel Bell,Danielle Van Patten,Sowmya Sreekanth,John H. Alexander,Carmelo A. Milano,Donald D. Glower,Joseph P. Mathew,J. Kevin Harrison,Stacey Welsh,Mark F. Berry,Cyrus J. Parsa,Betty C. Tong,Judson B. Williams,T. Bruce Ferguson,Alan P. Kypson,Evelio Rodriguez,Malissa Harris,Brenda Akers,Allison O'Neal,John D. Puskas,Robert A. Guyton,Jefferson Baer,Kim T. Baio,Alexis A. Neill,Mario Senechal,François Dagenais,Kim O'Connor,Gladys Dussault,Tatiana Ballivian,Suzanne Keilani,Alan M. Speir,Magee Pg,Niv Ad,Sally Keyte,Minh Dang,Mark S. Slaughter,Marsha Headlee,Heather Moody,Naresh Solankhi,Emma J. Birks,Mark A. Groh,Leslie E. Shell,Stephanie A. Shepard,Benjamin H. Trichon,Tracy Nanney,Lynne C. Hampton,David A. D'Alessandro,Joseph J. DeRose,Daniel J. Goldstein,Ricardo Bello,William Jakobleff,Mario J. Garcia,Cynthia C. Taub,Daniel Spevak,Roger Swayze,Arsène Basmadjian,Denis Bouchard,Michel Carrier,Raymond Cartier,Michel Pellerin,Jean Francois Tanguay,Ismail El-Hamamsy,André Y. Denault,Philippe Demers,Sophie Robichaud,Keith A. Horvath,Philip C. Corcoran,Michael P. Siegenthaler,Mandy Murphy,Ann Greenberg,Chittoor B. Sai-Sudhakar,Ayseha Hasan,Asia McDavid,Bradley Kinn,Pierre Pagé,Carole Sirois,David A. Latter,Howard Leong-Poi,Daniel Bonneau,Lee Errett,Mark D. Peterson,Subodh Verma,Randi Feder-Elituv,Gideon Cohen,Campbell D. Joyner,Stephen E. Fremes,Fuad Moussa,George T. Christakis,Reena Karkhanis,Terry Yau,Michael E. Farkouh,Anna Woo,Robert J. Cusimano,Tirone E. David,Christopher M. Feindel,Lisa Garrard,Suzanne Fredericks,Amelia Mociornita,John C. Mullen,Jonathan Choy,Steven R. Meyer,Emily Kuurstra,Cindi A. Young,Dana Beach,Pavan Atluri,Y. Joseph Woo,Mary Lou Mayer,Michael E. Bowdish,Vaughn A. Starnes,David Shavalle,Ray Matthews,Shadi Javadifar,Linda Romar,Irving L. Kron,Karen C. Johnston,John M. Dent,John A. Kern,Jessica Keim,Sandra G. Burks,Kim Gahring,David A. Bull,Patrice Desvigne-Nickens,Dennis O. Dixon,Mark C. Haigney,Richard Holubkov,Alice K. Jacobs,Frank Miller,John M. Murkin,John A. Spertus,Andrew S. Wechsler,Frank W. Sellke,Cheryl L. McDonald,Robert Byington,Neal W. Dickert,John S. Ikonomidis,David O. Williams,Clyde W. Yancy,James C. Fang,Nadia Giannetti,Wayne E. Richenbacher,Vivek Rao,Karen L. Furie,Rachel Miller,Sean Pinney,William C. Roberts,Mary Norine Walsh,Stephen J. Keteyian,Clinton A. Brawner,Heather Aldred,Judy Hung,Xin Zeng,Jeffrey N. Browndyke,Yanne Toulgoat-Dubois +249 more
TL;DR: The addition of mitral valve repair to coronary artery bypass grafting for patients with moderate ischemic mitral regurgitation is unlikely to be cost-effective and only if late mortality benefits can be demonstrated will it meet commonly used cost-effectiveness criteria.